
Obalon Therapeutics, Inc. Retained Earnings 2011-2026 | OBLN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -185 M | -172 M | -149 M | -111 M | -76.6 M | -56.1 M | -40.6 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -40.6 M | -185 M | -113 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | ||
|
Insulet Corporation
PODD
|
287 M | $ 216.0 | -4.21 % | $ 15.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | ||
|
Profound Medical Corp.
PROF
|
-130 M | $ 5.82 | 13.01 % | $ 180 M | ||
|
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | ||
|
Quanterix Corporation
QTRX
|
-577 M | $ 3.96 | 3.66 % | $ 169 M | ||
|
AVITA Medical
RCEL
|
-408 M | $ 3.99 | 3.91 % | $ 111 M | ||
|
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-79 M | $ 1.33 | -1.85 % | $ 21.5 M | ||
|
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | ||
|
IRadimed Corporation
IRMD
|
64.2 M | $ 101.78 | 0.8 % | $ 1.29 B | ||
|
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
-292 M | $ 2.56 | -0.39 % | $ 7.1 M | ||
|
CONMED Corporation
CNMD
|
589 M | $ 37.08 | 1.42 % | $ 1.15 B | ||
|
Smith & Nephew plc
SNN
|
4.96 B | - | - | $ 23.8 B | ||
|
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | ||
|
Sensus Healthcare
SRTS
|
5.72 M | $ 4.22 | 6.57 % | $ 68.9 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
21.2 M | $ 24.66 | -0.16 % | $ 208 M | ||
|
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | ||
|
Tactile Systems Technology
TCMD
|
54.9 M | $ 26.96 | 0.37 % | $ 617 M | ||
|
TELA Bio
TELA
|
-321 M | $ 0.69 | -9.35 % | $ 15.8 M | ||
|
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 24.26 | -1.02 % | $ 1.65 B | ||
|
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.67 | -3.52 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
-168 M | $ 2.32 | 7.41 % | $ 3.62 M | ||
|
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | ||
|
InspireMD
NSPR
|
-302 M | $ 1.77 | -1.12 % | $ 114 M | ||
|
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.39 | -0.78 % | $ 1.54 B | ||
|
Penumbra
PEN
|
238 M | $ 336.27 | 0.63 % | $ 13.1 B | ||
|
Myomo
MYO
|
-119 M | $ 0.7 | -0.1 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.29 | -4.58 % | $ 134 M | ||
|
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.71 | -5.12 % | $ 138 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.23 | 2.01 % | $ 381 M | ||
|
Outset Medical
OM
|
-1.17 B | $ 3.53 | - | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
-146 M | $ 51.41 | -1.27 % | $ 1.51 B | ||
|
Varex Imaging Corporation
VREX
|
-5.9 M | $ 10.69 | 0.66 % | $ 443 M |